1.4T study of proton magnetic relaxation rates, iron concentrations, and plaque burden in Alzheimer's disease and control postmortem brain tissue

Magnetic Resonance in Medicine

Volumn 60, Issue 1, 2008, Pages 41-52

  House, Michael J ^a   St Pierre, Timothy G ^a   McLean, Catriona ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b National Neural Tissue Resource Centre   (Australia)

Author keywords

Alzheimer's disease; Brain iron; MRI; R1; R2

Indexed keywords

BRAIN; DISEASE CONTROL; GLYCOPROTEINS; IRON; MAGNETIC RESONANCE IMAGING; NEURODEGENERATIVE DISEASES; REGRESSION ANALYSIS; TISSUE;

ALZHEIMER'S DISEASE; BRAIN IRON; FREQUENCY ANALYSIS; IRON CONCENTRATIONS; LINEAR CORRELATION; MULTIPLE REGRESSION MODEL; REGRESSION MODEL; RELAXATION RATES;

CHEMICALS REMOVAL (WATER TREATMENT);

IRON;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; AUTOPSY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG BRAIN LEVEL; FREQUENCY ANALYSIS; GRAY MATTER; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON TRANSPORT; REGRESSION ANALYSIS; RELAXATION TIME; SENILE PLAQUE; WATER CONTENT;

EID: 46849099649     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21586     Document Type: Article

References (44)

1. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004;5:863-873.
2. Religa D, Strozyk D, Cherny RA, Volitakis I, Haroutunian V, Winblad B, Naslund J, Bush AI. Elevated cortical zinc in Alzheimer disease. Neurology 2006;67:69-75.
3. Perry G, Nunomura A, Hirai K, Zhu X, Perez M, Avila J, Castellani RJ, Atwood CS, Aliev G, Sayre LM, Takeda A, Smith MA. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med 2002;33:1475-1479.
4. Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 1992;31:327-335.
5. Cornett CR, Markesbery WR, Ehmann WD. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 1998;19:339-346.
6. Deibel MA, Ehmann WD, Markesbery WR. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 1996;143: 137-142.
7. Ehmann WD, Markesbery WR, Alauddin M, Hossain TI, Brubaker EH. Brain trace elements in Alzheimer's disease. Neurotoxicology 1986;7: 195-206.
8. Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA. Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem 1995;65:710-716.
9. Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P. A quantitative analysis of isoferritins in select regions of the aged, Parkinsonian, and Alzheimer's diseased brains. J Neurochem 1995;65:717-724.
10. Connor JR, Menzies SL, St. Martin SM, Mufson EJ. A histochemical study of iron, transferrin and ferritin in Alzheimer's diseased brains. J Neurosci Res 1992;31:75-83.
11. Smith MA, Harris PL, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 1997;94:9866-9868.
12. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998;158:47-52.
13. Good PF, Perl DP, Bierer LM, Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 1992;31:286-292.
14. Watt F. Nuclear microscope analysis in Alzheimer's and Parkinson's disease: a review. Cell Mol Biol 1996;42:17-26.
15. Quintana CC, Bellefqih SS, Laval JJY, Guerquin-Kern JJL, Wu TTD, Avila JJ, Ferrer II, Arranz RR, Patiño CC. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol 2006;153: 42-54.
16. House MJ, St Pierre TG, Kowdley KV, Montine T, Connor J, Beard J, Berger J, Siddaiah N, Shankland E, Jin LW. Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from Alzheimer's disease patients. Magn Reson Med 2007; 57:172-180.
17. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc Natl Acad Sci U S A 1999;96:14079-14084.
18. Dhenain M, Privat N, Duyckaerts C, Jacobs RE. Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images. NMR Biomed 2002;15:197-203.
19. Huesgen CT, Burger PC, Crain BJ, Johnson GA. In vitro MR microscopy of the hippocampus in Alzheimer's disease. Neurology 1993;43:145-152.
20. Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J Struct Biol 2006;155:30-37.
21. Braakman N, Matysik J, van Duinen SG, Verbeek F, Schliebs R, de Groot HJM, Alia AA. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. J Magn Reson Imaging 2006;24:530-536.
22. Jack CR Jr, Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Adriany G, Poduslo JF. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J Neurosci 2005;25:10041-10048.
23. Falangola MF, Lee SP, Nixon RA, Duff K, Helpern JA. Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice. Neurochem Res 2005;30:201-205.
24. El Tannir El Tayara N, Delatour B, Le Cudennec C, Guegan M, Volk A, Dhenain M. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 2006;22:199-208.
25. Falangola MF, Dyakin VV, Lee SP, Bogart A, Babb JS, Duff K, Nixon R, Helpern JA. Quantitative MRI reveals aging-associated T2 changes in mouse models of Alzheimer's disease. NMR Biomed 2007;20:343-351.
26. Schenck JF, Zimmerman EA, Li Z, Adak S, Saha A, Tandon R, Fish KM, Beiden C, Gillen RW, Barba A, Henderson DL, Neil W, O'Keefe T. High-field magnetic resonance imaging of brain iron in Alzheimer disease. Top Magn Reson Imaging 2006;17:41-50.
27. Bartzokis G, Sultzer D, Cummings J, Holt LE, Hance DB, Henderson VW, Mintz J. In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry 2000;57:47-53.
28. House MJ, St Pierre TG, Foster JK, Martins RN, Clarnette R. Quantitative MR Imaging R2 relaxometry in elderly participants reporting memory loss. AJNR 2006;27:430-439.
29. Laasko MP, Partanen K, Soininen H, Lehtovirta M, Hallikainen M, Hanninen T, Helkala EL, Vainio P, Riekkinen PJ Sr. MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment. Neurobiol Aging 1996;17:535-540.
30. Bancroft JD, Gamble M. Theory and practice of histological techniques. London: Churchill Livingstone; 2002.
31. Griffiths PD, Crossman AR. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. Dementia 1993;4:61-65.
32. Besson JA, Best PV, Skinner ER. Post-mortem proton magnetic resonance spectrometric measures of brain regions in patients with a pathological diagnosis of Alzheimer's disease and multi-infarct dementia. Br J Psychiatry 1992;160:187-190.
33. Englund E, Brun A, Persson B. Correlations between histopathologic white matter changes and proton MR relaxation times in dementia. Alzheimer Dis Assoc Disord 1987;1:156-170.
34. Besson JAO, Corrigan FM, Iljon Foreman E, Eastwood LM, Smith FW, Ashcroft GW. Nuclear magnetic resonance (NMR): II. Imaging in dementia. Br J Psychiatry 1985;146:31-35.
35. Koenig SH, Brown RD III, Gibson JF, Ward RJ, Peters TJ. Relaxometry of ferritin solutions and the influence of the Fe3+ core ions. Magn Reson Med 1986;3:755-767.
36. Engelhardt R, Langkowski JH, Fischer R, Nielsen P, Kooijman H, Heinrich HC, Bucheler E. Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis. Magn Reson Imaging 1994;12:999-1007.
37. Vymazal J, Zak O, Bulte JWM, Aisen P, Brooks RA. T-1 and T-2 of ferritin solutions: effect of loading factor. Magn Reson Med 1996;36: 61-65.
38. Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem 2000;74:270-279.
39. Vymazal J, Brooks RA, Baumgarner C, Tran V, Katz D, Bulte JWM, Bauminger ER, DiChiro G. The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med 1996;35:56-61.
40. Chen JC, Hardy PA, Clauberg M, Joshi JG, Parravano J, Deck JH, Henkelman RM, Becker LE, Kucharczyk W. T2 values in the human brain: comparison with quantitative assays of iron and ferritin. Radiology 1989;173:521-526.
41. Hardy PA, Gash D, Yokel R, Andersen A, Ai Y, Zhang Z. Correlation of R2 with total iron concentration in the brains of rhesus monkeys. J Magn Reson Imaging 2005;21:118-127.
42. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991;12:295-312.
43. Schenck JF. Imaging of brain iron by magnetic resonance: T-2 relaxation at different field strengths. J Neurol Sci 1995;134:10-18.
44. Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, Tang CY, Aguinaldo G, Pappolla M, Duff K, Wisniewski T, Turnbull DH. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003;50:293-302.